India -
angol -
Central Drugs Standard Control Organization
ptp-40 vial inj
namas - pantoprazole - inj - 40mg - vial
Egyesült Államok -
angol -
NLM (National Library of Medicine)
magic pouch- alcohol kit
merci handy corporation - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - for handwashing to decrease bacteria on the skin - for handwashing to decrease bacteria on the skin for handwashing to decrease bacteria on the skin
Egyesült Államok -
angol -
NLM (National Library of Medicine)
gurunanda hand sanitizer spearmint- hand sanitizer spray
gurunanda, llc - isopropyl alcohol (unii: nd2m416302) (isopropyl alcohol - unii:nd2m416302) - antiseptic stop use and ask a doctor if irritation or rash appears and lasts for more than 72 hours. hand sanitizer to reduce germs on skin
Olaszország -
angol -
Ministero della Salute
spongostan polvere di gelatina emostatica riassorbibile
Olaszország -
angol -
Ministero della Salute
cpg 312 gel breast implant cohesive iii, low height, moderate plus profile
Európai Unió -
angol -
EMA (European Medicines Agency)
cayston
gilead sciences ireland uc - aztreonam lysine - cystic fibrosis; respiratory tract infections - antibacterials for systemic use, - cayston is indicated for the suppressive therapy of chronic pulmonary infections due to pseudomonas aeruginosa in patients with cystic fibrosis (cf) aged 6 years and older.consideration should be given to official guidance on the appropriate use of antibacterial agents.
Új-Zéland -
angol -
Medsafe (Medicines Safety Authority)
zerbaxa
merck sharp & dohme (new zealand) limited - ceftolozane sulfate 1147mg equivalent to ceftolozane 1000 mg; tazobactam sodium 537mg equivalent to tazobactam 500 mg - powder for injection - 1000mg/500mg - active: ceftolozane sulfate 1147mg equivalent to ceftolozane 1000 mg tazobactam sodium 537mg equivalent to tazobactam 500 mg excipient: arginine citric acid sodium chloride - zerbaxa (ceftolozane/tazobactam) is indicated for the treatment of the following infections in adults and paediatric (birth to less than 18 years of age) patients with the following infections caused by designated susceptible microorganisms: - complicated intra-abdominal infections in combination with metronidazole. - complicated urinary tract infections, including pyelonephritis. consideration should be given to published therapeutic guidelines on the appropriate use of antibacterial agents.